Clinical Trials

CASANA
  • CGuard™
  • PI: Casana,
  • 82 consecutive patients
  • A single centre study
  • FU: 30 day results soon to  be published
WISSGOTT
  • CGuard™
  • PI: Christian Wissgott and Reimer Andresen
  • 30 Consecutive patients
  • Prospective single-center study
  • FU: 6 month clinical results demonstrate a very safe implantation behavior without any stroke up to 6 months after the procedure
Summary
IRON-GUARD
  • CGuard™
  • PI: Carlo Setacci and Francesco Speziale
  • 200 consecutive patients
  • Physician-initiated prospective multicenter study
  • Primary endpoint: Technical and procedural success, periprocedural major and minor stroke, death, and TIA rates
  • FU: 30 day results published
PARADIGM
  • CGuard™
  • PI: Piotr Musialek
  • 101 symptomatic and high-risk asymptomatic patients
  • A prospective, all-referral-study
  • Follow-up: Study will continue to include up to 250 patients
CARENET
  • CGuardTM
  • PI: Joachim Schofer; Co-PI: Piotr Musialek
  • 30 carotid artery stenting patients
  • Prospective, multi-center, international, open label, single arm, non-randomized
  • Primary endpoint: 30 day MACE (death, stroke, MI)
  • Follow-up